Bolak Co

Bolak Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Bolak Co (002760.KS) as of Oct 28, 2026 is 252.45 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -42.15 % — a change of -699.00% (higher).

FCF Conversion

252.45 %

YoY

-699.00%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Bolak Co is 2025 252.45 % . FCF Conversion Rate (FCF/EBITDA) of Bolak Co was 2024 -42.15 % . It decreases by -699.00% higher compared to the previous year.

The Bolak Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-28.98 KRW
Jan 1, 2019
-154.71 KRW
Jan 1, 2020
60.89 KRW
Jan 1, 2021
32.37 KRW
Jan 1, 2022
61.87 KRW
Jan 1, 2023
111.20 KRW
Jan 1, 2024
-42.15 KRW
Jan 1, 2025
252.45 KRW
The Bolak Co FCF Conversion history
YEARFCF ConversionYoY
252.45 %-699.00%
-42.15 %-137.90%
111.20 %+79.74%
61.87 %+91.10%
32.37 %-46.83%
60.89 %-139.36%
-154.71 %+433.81%
-28.98 %-11.41%
-32.71 %-132.96%
99.26 %-126.91%
-368.83 %-818.05%
51.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co Stock analysis

What does Bolak Co do? Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients. Bolak Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bolak Co stock

FCF Conversion Rate (FCF/EBITDA) of Bolak Co is 252.45 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Bolak Co changed from -42.15 % to 252.45 %, representing a -699.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Bolak Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Bolak Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bolak Co

All Key Metrics — Bolak Co